Raj K. Maturi, MD, PC

Indianapolis, Indiana 46290

1 studies enrolling now · 37 studies all time

What they study most

Age-Related Macular Degeneration, Anterior Uveitis, Diabetes, Diabetic Macular Edema, Diabetic Retinopathy, Epiretinal Membrane, Exudative Age Related Macular Degeneration, Exudative Age-related Macular Degeneration, Full-thickness Macular Holes (MH), Geographic Atrophy, Macular Degeneration, Neovascular Age-related Macular Degeneration

Studies at this site

• Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM — Recruiting now
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema — Completed
• An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration — Running, not enrolling
• A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Participants With Diabetic Macular Edema Treated With Faricimab — Completed
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE) — Completed
• A Study of NGM621 in Participants With Geographic Atrophy — Completed
• NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) — Completed
• DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME — Completed
• Anti-VEGF Treatment for Prevention of PDR/DME — Completed
• A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration — Completed
• A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration — Completed
• Effects of Pneumatic Vitreolysis on Vitreomacular Traction — Completed
• A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema — Completed
• Effects of Pneumatic Vitreolysis on Macular Hole — Completed
• Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy — Completed
• A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated. — Completed
• A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD) — Completed
• Assessment of Novel Intraocular Injection Guide — Completed
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
• A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD) — Completed
• A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration — Completed
• Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema — Completed
• Evaluation of Vitrectomy for Diabetic Macular Edema — Completed
• Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed
• Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD — Completed
• Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD — Completed
• A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME — Completed
• Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema — Completed
• A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) — Completed
• Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control — Completed
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) — Completed
• Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy — Completed
• The Course of Response to Focal Photocoagulation for DME — Completed
• Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema — Completed
• Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis — Completed